@whytee @DocMcstuffins
I distinctly recall SI saying in one webcast a few years ago MSB would be willing to run a RCT in high risk adults against something approved and therefore Ruxolitinib if that's what the FDA required.
I can't find the link now but prior to this (at least a year), I also distinctly recall an interview with KOL Dr. Susan Prockop saying that after her center's experience of treating 3 patients with Rux (She was very specific about the effects) they wouldn't be participating in a clinical trial.
Why would she say this unless she'd been asked?
I'd be grateful if you could both answer the following questions "yes" or "no"
1. Is it a fact that Dr Prockop was never asked to participate in a RCT in Ryoncil?
2. Is it your opinion that if a randomised controlled study in adults did go ahead and showed no efficacy (unlikely IMO), that would be proof it wasn't effective in children either?
- Forums
- ASX - By Stock
- Cell Therapy News/Articles
@whytee @DocMcstuffinsI distinctly recall SI saying in one...
-
- There are more pages in this discussion • 526 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.09 |
Change
0.060(5.85%) |
Mkt cap ! $1.238B |
Open | High | Low | Value | Volume |
$1.03 | $1.10 | $1.02 | $6.406M | 6.038M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 313712 | $1.08 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.09 | 100000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 313712 | 1.075 |
2 | 30301 | 1.070 |
1 | 20501 | 1.065 |
4 | 67600 | 1.050 |
2 | 25072 | 1.045 |
Price($) | Vol. | No. |
---|---|---|
1.090 | 100000 | 1 |
1.095 | 50814 | 5 |
1.100 | 72846 | 10 |
1.105 | 46185 | 4 |
1.110 | 29041 | 4 |
Last trade - 16.10pm 17/05/2024 (20 minute delay) ? |
|
|||||
Last
$1.08 |
  |
Change
0.060 ( 5.29 %) |
|||
Open | High | Low | Volume | ||
$1.03 | $1.10 | $1.02 | 928883 | ||
Last updated 15.59pm 17/05/2024 ? |
Featured News
MSB (ASX) Chart |